ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (NASDAQ:RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, announced today that the company’s 2008 full year revenues are estimated to be $146.3 million and fourth quarter revenues are estimated to be $37.0 million. This compares to 2007 full year revenues of $94.2 million and fourth quarter revenues of $25.5 million. Management expects to be profitable from operations in the fourth quarter.
